Exact Mass: 408.1761216
Exact Mass Matches: 408.1761216
Found 500 metabolites which its exact mass value is equals to given mass value 408.1761216,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
senegalensin
6,8-diprenylnaringenin is a trihydroxyflavanone that is (S)-naringenin substituted by prenyl groups at positions 6 and 8. It has a role as a plant metabolite and an antibacterial agent. It is a trihydroxyflavanone, a member of 4-hydroxyflavanones and a (2S)-flavan-4-one. It is functionally related to a (S)-naringenin. Lonchocarpol A is a natural product found in Macaranga conifera, Erythrina suberosa, and other organisms with data available. A trihydroxyflavanone that is (S)-naringenin substituted by prenyl groups at positions 6 and 8.
Abyssinone V
Abyssinone V is a trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7 and 4 and prenyl groups at positions 3 and 5 respectively. It has a role as a metabolite. It is a member of phenols, a trihydroxyflavanone and a member of 4-hydroxyflavanones. Abyssinone V is a natural product found in Erythrina abyssinica, Azadirachta indica, and other organisms with data available. A trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7 and 4 and prenyl groups at positions 3 and 5 respectively.
Beclometasone
C22H29ClO5 (408.17034140000004)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
Tamsulosin
C20H28N2O5S (408.17188380000005)
Tamsulosin is a selective antagonist at alpha-1A and alpha-1B-adrenoceptors in the prostate, prostatic capsule, prostatic urethra, and bladder neck. At least three discrete alpha1-adrenoceptor subtypes have been identified: alpha-1A, alpha-1B and alpha-1D; their distribution differs between human organs and tissue. Approximately 70\\\% of the alpha1-receptors in human prostate are of the alpha-1A subtype. Blockage of these receptors causes relaxation of smooth muscles in the bladder neck and prostate. G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tamsulosin ((R)-(-)-YM12617 free base) is an inhibitor of α1-adrenergic receptor. Tamsulosin is used for the research of prostatic hyperplasia. Tamsulosin attenuates abdominal aortic aneurysm growth in animal models[1].
MK-329
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist Same as: D02693 Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1].
6-Geranylnaringenin
6-geranylnaringenin is a member of the class of compounds known as 6-prenylated flavanones. 6-prenylated flavanones are flavanones that features a C5-isoprenoid substituent at the 6-position. 6-geranylnaringenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6-geranylnaringenin can be found in beer, which makes 6-geranylnaringenin a potential biomarker for the consumption of this food product. Bonannione A is a natural product found in Diplacus clevelandii, Schizolaena hystrix, and other organisms with data available.
3-Hydroxyglabrol
3-Hydroxyglabrol is found in herbs and spices. 3-Hydroxyglabrol is from Glycyrrhiza glabra (licorice
3'-Geranyl-2',3,4,4'-tetrahydroxychalcone
3-Geranyl-2,3,4,4-tetrahydroxychalcone is found in fruits. 3-Geranyl-2,3,4,4-tetrahydroxychalcone is a constituent of Artocarpus incisus (breadfruit). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors Constituent of Artocarpus incisus (breadfruit). 3-Geranyl-2,3,4,4-tetrahydroxychalcone is found in fruits.
(E)-2'-Geranyl-3',4',7-trihydroxyflavanone
(E)-2-Geranyl-3,4,7-trihydroxyflavanone is found in fruits. (E)-2-Geranyl-3,4,7-trihydroxyflavanone is a constituent of Artocarpus communis (breadfruit). Constituent of Artocarpus communis (breadfruit). (E)-2-Geranyl-3,4,7-trihydroxyflavanone is found in fruits.
Bakkenolide D
C21H28O6S (408.16065080000004)
Constituent of Petasites japonicus (sweet coltsfoot). Bakkenolide D is found in giant butterbur and green vegetables. Bakkenolide D is found in giant butterbur. Bakkenolide D is a constituent of Petasites japonicus (sweet coltsfoot)
3-O-Methylniveusin A
3-O-Methylniveusin A is found in fats and oils. 3-O-Methylniveusin A is a constituent of Helianthus annuus (sunflower). Constituent of Helianthus annuus (sunflower). 3-O-Methylniveusin A is found in fats and oils.
Kuwanol D
Kuwanol D is found in fruits. Kuwanol D is a constituent of Morus alba (white mulberry). Constituent of Morus alba (white mulberry). Kuwanol D is found in fruits.
1-Hydroxy-3,5-dimethoxy-2,4-diprenylxanthone
1-Hydroxy-3,5-dimethoxy-2,4-diprenylxanthone is found in fruits. 1-Hydroxy-3,5-dimethoxy-2,4-diprenylxanthone is a constituent of Garcinia mangostana (mangosteen). Constituent of Garcinia mangostana (mangosteen). 1-Hydroxy-3,5-dimethoxy-2,4-diprenylxanthone is found in fruits.
1-(2,4-Dihydroxyphenyl)-3-[8-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-1-benzopyran-5-yl]-1-propanone
1-(2,4-Dihydroxyphenyl)-3-[8-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-1-benzopyran-5-yl]-1-propanone is found in breadfruit. 1-(2,4-Dihydroxyphenyl)-3-[8-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-1-benzopyran-5-yl]-1-propanone is a constituent of Artocarpus communis (breadfruit) Constituent of Artocarpus communis (breadfruit). 1-(2,4-Dihydroxyphenyl)-3-[8-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-1-benzopyran-5-yl]-1-propanone is found in breadfruit and fruits.
3'-Geranyl-2',4,4',6'-tetrahydroxychalcone
3-Geranyl-2,4,4,6-tetrahydroxychalcone is found in alcoholic beverages. 3-Geranyl-2,4,4,6-tetrahydroxychalcone is a constituent of hops (Humulus lupulus) Constituent of hops (Humulus lupulus). 3-Geranyl-2,4,4,6-tetrahydroxychalcone is found in alcoholic beverages.
Alclometasone
C22H29ClO5 (408.17034140000004)
Alclometasone is only found in individuals that have used or taken this drug. It is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent. [Wikipedia]The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Alclometasone initially binds the corticosteroid receptor. This complex migrates to the nucleus where it binds to different glucocorticoid response elements on the DNA. This in turn enhances and represses various genes, especially those involved in inflammatory pathways. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(E)-2',4,4',6'-Tetrahydroxy-3',5'-diprenylchalcone
(E)-2,4,4,6-Tetrahydroxy-3,5-diprenylchalcone is found in alcoholic beverages. (E)-2,4,4,6-Tetrahydroxy-3,5-diprenylchalcone is a constituent of hops (Humulus lupulus)
beclomethasone
C22H29ClO5 (408.17034140000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
5-Benzyl-2-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]-6-methylpyridazin-3-one
N-[4-(Benzylamino)-3-cyanoquinolin-2-yl]-4-methoxybenzamide
Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-
C20H28N2O5S (408.17188380000005)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Xanthoangelol B
Xanthoangelol b is a member of the class of compounds known as 3-prenylated chalcones. 3-prenylated chalcones are chalcones featuring a C5-isoprenoid unit at the 3-position. Thus, xanthoangelol b is considered to be a flavonoid lipid molecule. Xanthoangelol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Xanthoangelol b can be found in angelica, which makes xanthoangelol b a potential biomarker for the consumption of this food product.
2-Prenyl-6alpha-hydroxyphaseollidin
2-prenyl-6alpha-hydroxyphaseollidin is a member of the class of compounds known as pterocarpans. Pterocarpans are benzo-pyrano-furano-benzene compounds, containing the 6H-[1]benzofuro[3,2-c]chromene skeleton. They are derivatives of isoflavonoids. Thus, 2-prenyl-6alpha-hydroxyphaseollidin is considered to be a flavonoid lipid molecule. 2-prenyl-6alpha-hydroxyphaseollidin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2-prenyl-6alpha-hydroxyphaseollidin can be found in lima bean, which makes 2-prenyl-6alpha-hydroxyphaseollidin a potential biomarker for the consumption of this food product.
Lochnocarpol A
Lochnocarpol a is a member of the class of compounds known as 8-prenylated flavanones. 8-prenylated flavanones are flavanones that features a C5-isoprenoid substituent at the 8-position. Lochnocarpol a is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lochnocarpol a can be found in sweet orange, which makes lochnocarpol a a potential biomarker for the consumption of this food product.
2,10-Di-(gamma,gamma-dimethylallyl)-glycinol
2,10-di-(gamma,gamma-dimethylallyl)-glycinol is a member of the class of compounds known as pterocarpans. Pterocarpans are benzo-pyrano-furano-benzene compounds, containing the 6H-[1]benzofuro[3,2-c]chromene skeleton. They are derivatives of isoflavonoids. 2,10-di-(gamma,gamma-dimethylallyl)-glycinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2,10-di-(gamma,gamma-dimethylallyl)-glycinol can be found in lima bean, which makes 2,10-di-(gamma,gamma-dimethylallyl)-glycinol a potential biomarker for the consumption of this food product.
KushenolA
Kushenol A is a natural product found in Sophora flavescens with data available. D004791 - Enzyme Inhibitors Kushenol A (Leachianone E) is isolated from the root of Sophora flavescent. Kushenol A is a non-competitive tyrosinase inhibitor to block the conversion of L-tyrosine to L-DOPA, shows IC50 and Kivalues of 1.1 μM and 0.4 μM, respectively[1]. Kushenol A is a flavonoid antioxidant, has inhibitory effects on alpha-glucosidase (IC50: 45 μM; Ki: 6.8 μM) and β-amylase[2]. Kushenol A is confirmed as potential inhibitors of enzymes targeted by cosmetics for skin whitening and aging[1]. Kushenol A (Leachianone E) is isolated from the root of Sophora flavescent. Kushenol A is a non-competitive tyrosinase inhibitor to block the conversion of L-tyrosine to L-DOPA, shows IC50 and Kivalues of 1.1 μM and 0.4 μM, respectively[1]. Kushenol A is a flavonoid antioxidant, has inhibitory effects on alpha-glucosidase (IC50: 45 μM; Ki: 6.8 μM) and β-amylase[2]. Kushenol A is confirmed as potential inhibitors of enzymes targeted by cosmetics for skin whitening and aging[1].
Kushenol A
D004791 - Enzyme Inhibitors Kushenol A (Leachianone E) is isolated from the root of Sophora flavescent. Kushenol A is a non-competitive tyrosinase inhibitor to block the conversion of L-tyrosine to L-DOPA, shows IC50 and Kivalues of 1.1 μM and 0.4 μM, respectively[1]. Kushenol A is a flavonoid antioxidant, has inhibitory effects on alpha-glucosidase (IC50: 45 μM; Ki: 6.8 μM) and β-amylase[2]. Kushenol A is confirmed as potential inhibitors of enzymes targeted by cosmetics for skin whitening and aging[1]. Kushenol A (Leachianone E) is isolated from the root of Sophora flavescent. Kushenol A is a non-competitive tyrosinase inhibitor to block the conversion of L-tyrosine to L-DOPA, shows IC50 and Kivalues of 1.1 μM and 0.4 μM, respectively[1]. Kushenol A is a flavonoid antioxidant, has inhibitory effects on alpha-glucosidase (IC50: 45 μM; Ki: 6.8 μM) and β-amylase[2]. Kushenol A is confirmed as potential inhibitors of enzymes targeted by cosmetics for skin whitening and aging[1].
6,4-Dihydroxy-3-(3,3-dimethylallyl)-2,2-dimethylchromene(5,6:5,4)-2-methoxy deoxybenzoin
Fukanemarin B
A hydroxycoumarin that is 4-hydroxycoumarin substituted by a methoxy group ar position 7 and a 1,2,6-trimethyl-7-(4-methyl-2-furyl)-hepta-2(E),5(E)-dienyl moiety at position 3. Isolated from the roots of Ferula fukanensis, it inhibits production of nitric oxide (NO).
Cedrediprenone
Euchrestaflavanone A
Euchrestaflavanone A is a member of flavanones. Euchrestaflavanone A is a natural product found in Azadirachta indica, Erythrina subumbrans, and other organisms with data available.
Lehmannin
SSR161421
CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4517; ORIGINAL_PRECURSOR_SCAN_NO 4515 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4524 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4486; ORIGINAL_PRECURSOR_SCAN_NO 4482 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4512; ORIGINAL_PRECURSOR_SCAN_NO 4511 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4511; ORIGINAL_PRECURSOR_SCAN_NO 4509 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4499; ORIGINAL_PRECURSOR_SCAN_NO 4496 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8790; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8826; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8842; ORIGINAL_PRECURSOR_SCAN_NO 8841 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8870; ORIGINAL_PRECURSOR_SCAN_NO 8865 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8884; ORIGINAL_PRECURSOR_SCAN_NO 8882 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8898; ORIGINAL_PRECURSOR_SCAN_NO 8897 ORIGINAL_PRECURSOR_SCAN_NO 8897; CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8898
3beta-acetoxy-6beta-isobutyryloxy-seco-macrotolide
12,13-epoxytrichothec-9-ene-3alpha,4beta,15-triyl triacetate|3,4,15-Triacetoxy-scirpen|3,4,15-triacetoxyscirpene|3,4,15-triacetoxyscirpenol|3alpha,4beta,15-triacetoxy-12,13-epi-epoxytrichothec-9-ene|3alpha,4beta,15-Triacetoxy-scirpen|3alpha,4beta,15-triacetoxyscirpene|3alpha-acetyl-4beta,15-diacetoxyscirpenol|3alpha-acetyldiacetoxyscirpenol|triacetoxyscirpene|Triacetoxyscirpenol
1alpha-methoxy-3alpha,15-dihydroxy-3,10-epoxy-8beta-O-angeloyl-4,11(13)-germacradien, 6alpha,12-olide
1-(4-Hydroxy-3-methoxyphenyl)-2-(4-(3-hydroxypropyl)-2,6-dimethoxyphenoxy)propane-1,3-diol
2,3-Dimethoxy-7,8-didehydro-7,16-seco-strychnidin-10,16-dion|2,3-dimethoxy-7,8-didehydro-7,16-seco-strychnidine-10,16-dione
(2R,3R,6R)-7-(2,3-dihydroxy-6,7-epoxy-3,7-dimethyloctyloxy)-6,8-dimethoxycoumarin|altissimacoumarin E
1-O-(3-methylbut-3-en-1-yl)-6-O-beta-D-xylopyranosyl-beta-D-glucopyranose|nonioside L
C17H28O11 (408.16315380000003)
5-oxobrucine
A monoterpenoid indole alkaloid with formula C23H24N2O5, originallly isolated from the seeds of Strychnos nux-vomica.
(1alpha,3alpha)-8beta-glucopyranosyl-1H-lindan-4(15),7(11)-dien-12,8alpha-olide|chlorajaposide
ent-4beta-methyl-6beta,7beta,11alpha-trihydroxy-19-acetoxy-7alpha,10alpha-peroxy-simlikaur-16-en-15-one|taibaihenryiin T
8alpha-isobutyryloxyanthemolide C|8??-Isobutyryloxyanthemolide C
8beta-angeloyloxy-9beta-hydroxy-guaia-13-methoxy-6(12),4(14)-diolide
8alpha-methacryloyloxy-10alpha-hydroxy-1,13-bis-O-methyl hirsutinolide
Lychnostatin 1
A germacranolide isolated from Lychnophora antillana and has been shown to exhibit antineoplastic activity.
Bakkenolide D
C21H28O6S (408.16065080000004)
1,2-dehydro-3-oxocostic acid beta-D-glucopyranoside ester
8alpha-isobutyryloxyanthemolide A|8??-Isobutyryloxyanthemolide A
3beta-hydroxy-8-desacyl-2,3-dihydroereglomerulide-8-O-methacrylate
N-(1-Deoxyfructopyranos-1-yl)isoleucylaspartic acid
Ala Asp Phe Gly
Ala Asp Gly Phe
Ala Phe Asp Gly
Ala Phe Gly Asp
Ala Gly Asp Phe
Ala Gly Phe Asp
Ala Met Ser Thr
Ala Met Thr Ser
Ala Ser Met Thr
Ala Ser Thr Met
Ala Thr Met Ser
Ala Thr Ser Met
Cys Ile Ser Ser
Cys Leu Ser Ser
Cys Ser Ile Ser
Cys Ser Leu Ser
Cys Ser Ser Ile
Cys Ser Ser Leu
Cys Ser Thr Val
Cys Ser Val Thr
Cys Thr Ser Val
Cys Thr Val Ser
Cys Val Ser Thr
Cys Val Thr Ser
Asp Ala Phe Gly
Asp Ala Gly Phe
Asp Phe Ala Gly
Asp Phe Gly Ala
Asp Gly Ala Phe
Asp Gly Phe Ala
Glu Phe Gly Gly
Glu Gly Phe Gly
Glu Gly Gly Phe
Phe Ala Asp Gly
Phe Ala Gly Asp
Phe Asp Ala Gly
Phe Asp Gly Ala
Phe Glu Gly Gly
Phe Gly Ala Asp
Phe Gly Asp Ala
Phe Gly Glu Gly
Phe Gly Gly Glu
Gly Ala Asp Phe
Gly Ala Phe Asp
Gly Asp Ala Phe
Gly Asp Phe Ala
Gly Glu Phe Gly
Gly Glu Gly Phe
Gly Phe Ala Asp
Gly Phe Asp Ala
Gly Phe Glu Gly
Gly Phe Gly Glu
Gly Gly Glu Phe
Gly Gly Phe Glu
Gly Met Thr Thr
Gly Thr Met Thr
Gly Thr Thr Met
Ile Cys Ser Ser
Ile Ser Cys Ser
Ile Ser Ser Cys
Leu Cys Ser Ser
Leu Ser Cys Ser
Leu Ser Ser Cys
Met Ala Ser Thr
Met Ala Thr Ser
Met Gly Thr Thr
Met Ser Ala Thr
Met Ser Thr Ala
Met Thr Ala Ser
Met Thr Gly Thr
Met Thr Ser Ala
Met Thr Thr Gly
Ser Ala Met Thr
Ser Ala Thr Met
Ser Cys Ile Ser
Ser Cys Leu Ser
Ser Cys Ser Ile
Ser Cys Ser Leu
Ser Cys Thr Val
Ser Cys Val Thr
Ser Ile Cys Ser
Ser Ile Ser Cys
Ser Leu Cys Ser
Ser Leu Ser Cys
Ser Met Ala Thr
Ser Met Thr Ala
Ser Ser Cys Ile
Ser Ser Cys Leu
Ser Ser Ile Cys
Ser Ser Leu Cys
Ser Thr Ala Met
Ser Thr Cys Val
Ser Thr Met Ala
Ser Thr Thr Thr
C15H28N4O9 (408.18561980000004)
Ser Thr Val Cys
Ser Val Cys Thr
Ser Val Thr Cys
Thr Ala Met Ser
Thr Ala Ser Met
Thr Cys Ser Val
Thr Cys Val Ser
Thr Gly Met Thr
Thr Gly Thr Met
Thr Met Ala Ser
Thr Met Gly Thr
Thr Met Ser Ala
Thr Met Thr Gly
Thr Ser Ala Met
Thr Ser Cys Val
Thr Ser Met Ala
Thr Ser Thr Thr
C15H28N4O9 (408.18561980000004)
Thr Ser Val Cys
Thr Thr Gly Met
Thr Thr Met Gly
Thr Thr Ser Thr
C15H28N4O9 (408.18561980000004)
Thr Thr Thr Ser
C15H28N4O9 (408.18561980000004)
Thr Val Cys Ser
Thr Val Ser Cys
Val Cys Ser Thr
Val Cys Thr Ser
Val Ser Cys Thr
Val Ser Thr Cys
Val Thr Cys Ser
Val Thr Ser Cys
3-O-Methylniveusin A
6,8-Difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid ethyl ester
C19H22F2N4O4 (408.16090360000004)
TERT-BUTYL 4-(4-CHLORO-2-(4,4-DIMETHYL-4,5-DIHYDROOXAZOL-2-YL)PHENYL)-4-HYDROXYPIPERIDINE-1-CARBOXYLATE
C21H29ClN2O4 (408.18157440000004)
(s)-(+)-nalpha-benzyl-nbeta-boc-l-hydrazinotryptophane
C23H26N3O4 (408.19232160000007)
2-[(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxoazepan-1-yl]acetic acid
2-amino-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoic acid,hydrochloride
C16H29ClN4O4S (408.15979440000007)
AZD6482
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
dipropyl 3,6-diphenyl-1,2,4,5-tetrazine-1,2-dicarboxylate
(R)-2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoic acid
11,12-Dihydro-11,12-diphenylindolo[2,3-a]carbazole
Triethylene glycol 4-methylbenzyl ether tosylate
C21H28O6S (408.16065080000004)
Ethyl (2R,4R)-1-(Nitroglycerine-nitro-L-arginyl)-4-Methyl-piperidinecarboxylate hydrochloride
C15H29ClN6O5 (408.18878540000003)
(+)-Tamsulosin
C20H28N2O5S (408.17188380000005)
N-[4-(Benzylamino)-3-cyanoquinolin-2-yl]-4-methoxybenzamide
2-(5-butoxy-1-oxo-2-isoquinolinyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide
N-[3-[2-(1-cyclohexenyl)ethylamino]-2-quinoxalinyl]benzenesulfonamide
[1-(1-Methyl-4,5-dioxo-pent-2-enylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester
1-Decyl-3-trifluoro ethyl-SN-glycero-2-phosphomethanol
Alclometasone
C22H29ClO5 (408.17034140000004)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
[(1S,2R,10R,11S)-10,11-diacetyloxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
10-[3-(4-Methylpiperazin-1-ium-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
C21H25F3N3S+ (408.17211860000003)
Devazepide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1].
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
C22H29ClO5 (408.17034140000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-phenylacetamide
2-Cyano-3-{4-[(2,4-dimethyl-phenylcarbamoyl)-methoxy]-3-methoxy-phenyl}-acrylic acid ethyl ester
3-hydroxy-2-(3-methylphenyl)-5-nitro-N-[1-(phenylmethyl)-4-piperidinyl]-4-triazolimine
C21H24N6O3 (408.19097939999995)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
C19H28N4O4S (408.18311680000005)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
C19H28N4O4S (408.18311680000005)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
C19H28N4O4S (408.18311680000005)
[(1R,2aR,8bR)-4-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopentylmethanone
1-[(2S,3S)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2S,3S)-6-(4-fluorobenzoyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
C19H28N4O4S (408.18311680000005)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
C19H28N4O4S (408.18311680000005)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
C19H28N4O4S (408.18311680000005)
[(1S,2aS,8bS)-4-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopentylmethanone
[(1S,2aR,8bR)-4-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopentylmethanone
[(1R,2aS,8bS)-4-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-cyclopentylmethanone
1-[(2R,3R)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2S,3R)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2R,3R)-6-(4-fluorobenzoyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
1-[(2S,3R)-6-(4-fluorobenzoyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
(Z)-2-cyano-N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-3-naphthalen-2-ylprop-2-enamide
(2S)-2-[(2-aminoacetyl)amino]-N-[2-[2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]ethyldisulfanyl]ethyl]propanamide
(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-tridec-9-enoate
C18H33O8P (408.19129480000004)
Tamsulosin
C20H28N2O5S (408.17188380000005)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tamsulosin ((R)-(-)-YM12617 free base) is an inhibitor of α1-adrenergic receptor. Tamsulosin is used for the research of prostatic hyperplasia. Tamsulosin attenuates abdominal aortic aneurysm growth in animal models[1].
Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-
C20H28N2O5S (408.17188380000005)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
PA(15:1)
C18H33O8P (408.19129480000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LY2444296
LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ～1 nM. LY2444296 exhibits anti-anxiety like effects[1][2].
ONC206
ONC206 is an analogue of TRAIL inducer ONC201[1]. ONC206 is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 has broad-spectrum anti-tumor activity[2].
RBC10
RBC10 is an anti-cancer agent. RBC10 inhibits the binding of Ral to its effector RALBP1. RBC10 also inhibits Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines[1].
(1s,2e,8r,10r,11s)-6-(ethoxymethyl)-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
(1s,2r,4r,7s,8s,10s)-7-(acetyloxy)-12-(hydroxymethyl)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylprop-2-enoate
2'-hydroxy-12'-isopropyl-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
1-hydroxy-2-(hydroxymethyl)-12-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylbut-2-enoate
(1s,2r,3s,7s,8r,9s,12s,13r,14r,15r,16r)-3,14,15-trihydroxy-2,6,13,16-tetramethyl-4,11-dioxo-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadec-5-en-8-yl acetate
methyl 6,7-dimethoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,18-heptaene-19-carboxylate
(1s,3r,8s,9s,10r,11s,13r)-11-(acetyloxy)-3-hydroxy-6,9,10-trimethyl-5-oxo-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradec-6-en-8-yl 2-methylpropanoate
(1r,2s,3s,6s,7s,8s,9r,10r,13s)-9-hydroxy-6-(methoxymethyl)-13-methyl-5,11-dioxo-4,12-dioxatetracyclo[8.5.0.0²,¹³.0³,⁷]pentadecan-8-yl (2z)-2-methylbut-2-enoate
butyl (3r,5r)-1,3,5-trihydroxy-4-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]cyclohexane-1-carboxylate
(1r,2e,8s,10r,11s)-10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl (2e)-2-methylbut-2-enoate
(1s,2r)-1-(4-hydroxy-3-methoxyphenyl)-2-[4-(3-hydroxypropyl)-2,6-dimethoxyphenoxy]propane-1,3-diol
methyl (1r,9r,10r,12r)-4-methoxy-15,20-dioxo-8,16-diazahexacyclo[8.8.2.2⁹,¹².0¹,⁹.0²,⁷.0¹²,¹⁶]docosa-2,4,6,13-tetraene-8-carboxylate
(3as,4s,5r,6r,11ar)-5-(acetyloxy)-6-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,8h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
4-(5-hydroxy-1,4-dimethoxy-7,8-dioxo-3-pentyl-3,4-dihydro-1h-2-benzopyran-6-yl)-2-methylbut-2-enoic acid
2-[2-(5-hydroxy-2-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}phenyl)ethylidene]-6-methylhept-4-enoic acid
3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
3,14,15-trihydroxy-2,6,13,16-tetramethyl-4,11-dioxo-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadec-5-en-8-yl acetate
(3as,4s,6r,9s,10s,11ar)-6-(acetyloxy)-9-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-octahydrocyclodeca[b]furan-4-yl 2-methylprop-2-enoate
(1s,2z,4s,8r,9r,11s,12r)-1-hydroxy-2-(hydroxymethyl)-12-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl (2z)-2-methylbut-2-enoate
(3as,6ar,8s,9ar,9br)-3,6,9-trimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(3ar,4as,5r,6r,7r,7as,8r,9ar)-5,6-bis(acetyloxy)-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
1-(4'-hydroxy-3'-m ethoxyphenyl)-2-[4''-(3-hydroxypropyl)-2'',6''-dimethoxyphenoxy]pro-pane-1,3-diol
{"Ingredient_id": "HBIN001472","Ingredient_name": "1-(4'-hydroxy-3'-m ethoxyphenyl)-2-[4''-(3-hydroxypropyl)-2'',6''-dimethoxyphenoxy]pro-pane-1,3-diol","Alias": "NA","Ingredient_formula": "C21H28O8","Ingredient_Smile": "COC1=CC(=CC(=C1OC(CO)C(C2=CC(=C(C=C2)O)OC)O)OC)CCCO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10445","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bakkenolide d
C21H28O6S (408.16065080000004)
{"Ingredient_id": "HBIN017535","Ingredient_name": "bakkenolide d","Alias": "NA","Ingredient_formula": "C21H28O6S","Ingredient_Smile": "CC1CCC(C2C1(CC3(C2OC(=O)C)C(=C)COC3=O)C)OC(=O)C=CSC","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2120","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137705098","DrugBank_id": "NA"}
7-{[(2r,3r)-5-[(2r)-3,3-dimethyloxiran-2-yl]-2,3-dihydroxy-3-methylpentyl]oxy}-6,8-dimethoxychromen-2-one
3-[(3-amino-5-carbamimidamido-1-hydroxypentylidene)amino]-6-(2-hydroxy-4-iminopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid
4-[2-(13-bromo-6,10-dimethyltrideca-3,5-dien-12-yn-2-yl)cyclopropyl]butanoic acid
10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylbut-2-enoate
(1s,2s,4r,7s,8r,10s)-12-[(acetyloxy)methyl]-7-hydroxy-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylprop-2-enoate
(1's,2s,2'r,3's,4e,5'r,7'r,8's,9'r,12's)-2'-hydroxy-12'-isopropyl-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
2-[(1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}butylidene)amino]pentanedioic acid
(4as,8s,8ar,9as)-3,8a-dimethyl-5-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h,4ah,8h,9h,9ah-naphtho[2,3-b]furan-2-one
3,5,8-trimethylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[6,5-b]furan-2-one
5,6-bis(acetyloxy)-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
3,6,9-trimethylidene-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(2r,3ar,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(1s,2z,4s,8r,9r,11s,12r)-12-hydroxy-2-(hydroxymethyl)-1-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl (2z)-2-methylbut-2-enoate
5-(acetyloxy)-6-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,10h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(3ar,4s,5r,6r,11ar)-5-(acetyloxy)-6-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,8h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
4-(acetyloxy)-5,9-dihydroxy-4a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 2-methylbut-2-enoate
12-hydroxy-2-(hydroxymethyl)-1-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylbut-2-enoate
3,5,8-trimethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7h,7ah,9h,9ah-azuleno[6,5-b]furan-2-one
(2s,3s)-2,3-dihydroxy-n-[(1s)-1-[(3s)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-4-[(1-hydroxyethylidene)amino]butanimidic acid
methyl (3as,4s,5s,10s,11ar)-5-hydroxy-10-(hydroxymethyl)-4-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,10h,11h,11ah-cyclodeca[b]furan-6-carboxylate
5a-methyl-3,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,8h,9ah,9bh-naphtho[1,2-b]furan-2-one
(1's,2s,2'r,3's,4z,5'r,7'r,8's,9'r,12's)-2'-hydroxy-12'-isopropyl-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-(4a-methyl-8-methylidene-7-oxo-2,3,4,8a-tetrahydro-1h-naphthalen-2-yl)prop-2-enoate
5-(acetyloxy)-6,10-bis(hydroxymethyl)-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(2s)-2-{[(2s)-2-{[(2r)-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid
{3,9,10-trihydroxy-12-methyl-6-methylidene-7-oxo-16,17-dioxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-12-yl}methyl acetate
(1r,2z,4s,8r,9s,11s,13s)-13-(acetyloxy)-1-hydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylpropanoate
(3as,4r,5r,6s,6ar,9r,9as,9bs)-5-(acetyloxy)-6,9-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(2s)-2-{[(2s,3s)-1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}pentylidene]amino}butanedioic acid
(2s)-2-{[(2s)-1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}butylidene]amino}pentanedioic acid
1-(4-hydroxy-3-methoxyphenyl)-2-[4-(3-hydroxypropyl)-2,6-dimethoxyphenoxy]propane-1,3-diol
2,3-dihydroxy-n-[1-(8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)-3-methylbutyl]-4-[(1-hydroxyethylidene)amino]butanimidic acid
9-hydroxy-6-(methoxymethyl)-13-methyl-5,11-dioxo-4,12-dioxatetracyclo[8.5.0.0²,¹³.0³,⁷]pentadecan-8-yl 2-methylbut-2-enoate
(2r,3r,3ar,4s,7s,7ar)-4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl (2z)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2z)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(3as,4r,4ar,5r,7s,7as,9r,9ar)-5-(acetyloxy)-4,9-dihydroxy-4a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl (2z)-2-methylbut-2-enoate
(3ar,4as,6s,7as,9as)-3,5,8-trimethylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[6,5-b]furan-2-one
(1s,2z,4r,8r,9r,11r,13s)-13-(acetyloxy)-1-hydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylpropanoate
(3as,4r,5r,6s,6ar,8r,9bs)-5-(acetyloxy)-6,8-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(s)-[(1r,5s,6r)-5-(acetyloxy)-2-formyl-1,6-dimethylcyclohex-2-en-1-yl][(2s)-2-hydroxy-4-methyl-5-oxo-2h-furan-3-yl]methyl 2-methylpropanoate
2-{16-methyl-20-oxo-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-11-yl}-2-oxoethyl acetate
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2e)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(1's,2s,2'r,7'r,9'r,10'r,11's)-10',11'-bis(acetyloxy)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
(3ar,4ar,6s,7ar,9as)-3,5,8-trimethylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[6,5-b]furan-2-one
5-(acetyloxy)-4,9-dihydroxy-4a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 2-methylbut-2-enoate
(1s,2z,4s,8r,9r,11s,12s)-12-hydroxy-2-(hydroxymethyl)-1-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl (2z)-2-methylbut-2-enoate
2,10-dihydroxy-11-(1-hydroxyhexa-2,4-dien-1-ylidene)-5-(hydroxymethyl)-5-methoxy-8,10-dimethyl-4-oxatricyclo[6.2.2.0²,⁷]dodecane-9,12-dione
12-[(acetyloxy)methyl]-7-hydroxy-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylprop-2-enoate
(2e,4r,8r,9r,13s)-13-(acetyloxy)-1-hydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylpropanoate
11-(acetyloxy)-3-hydroxy-6,9,10-trimethyl-5-oxo-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradec-6-en-8-yl 2-methylpropanoate
2-[(16r,17s,18r)-16-methyl-20-oxo-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-11-yl]-2-oxoethyl acetate
(3ar,4s,5r,6r,10r,11ar)-5-(acetyloxy)-6-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,10h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
[(1s,3s,5s,6s,8s)-6-hydroxy-1,3-dimethoxy-2-oxaspiro[4.5]decan-8-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
6-(acetyloxy)-9-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-octahydrocyclodeca[b]furan-4-yl 2-methylprop-2-enoate
(3as,5as,8r,9ar,9bs)-5a-methyl-3,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,8h,9ah,9bh-naphtho[1,2-b]furan-2-one
(1r,2e,8s,10r,11s)-6-(ethoxymethyl)-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
(1r,2s,5s,7r,8r,10s,11z)-2,10-dihydroxy-11-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-5-(hydroxymethyl)-5-methoxy-8,10-dimethyl-4-oxatricyclo[6.2.2.0²,⁷]dodecane-9,12-dione
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-[(2r,4as,8ar)-4a-methyl-8-methylidene-7-oxo-2,3,4,8a-tetrahydro-1h-naphthalen-2-yl]prop-2-enoate
(4as,8s,8ar,9as)-3,8a-dimethyl-5-methylidene-8-{[(2r,4s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h,4ah,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(7ar,8r,9as)-3,5,8-trimethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7h,7ah,9h,9ah-azuleno[6,5-b]furan-2-one
(1r,2r,3s,7s,8r,9s,12s,13r,14r,15r,16r)-3,14,15-trihydroxy-2,6,13,16-tetramethyl-4,11-dioxo-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadec-5-en-8-yl acetate
5-(acetyloxy)-6,9-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
4-[(1r,2r)-2-[(2s,3e,5e,10r)-13-bromo-6,10-dimethyltrideca-3,5-dien-12-yn-2-yl]cyclopropyl]butanoic acid
(3as,6ar,8s,9ar,9bs)-3,6,9-trimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
10',11'-bis(acetyloxy)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
9'-(acetyloxy)-12'-[(acetyloxy)methyl]-3'-methyl-10'-oxaspiro[oxirane-2,7'-tricyclo[6.4.0.0²,⁴]dodecan]-11'-en-3'-ylmethyl acetate
methyl 5-hydroxy-10-(hydroxymethyl)-4-[(2-methylbut-2-enoyl)oxy]-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,10h,11h,11ah-cyclodeca[b]furan-6-carboxylate
(3as,5r,6ar,9ar,9bs)-3,6,9-trimethylidene-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(2s,3s,6r)-3-{[(3s)-3-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-6-(2-hydroxy-4-iminopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid
(3as,4s,5r,6r,10r,11ar)-5-(acetyloxy)-6-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,10h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(7s,8s)-5-chloro-7-hydroxy-8-[(3s,4s)-4-hydroxy-3-methyl-2-oxopentyl]-7-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-8h-isochromen-6-one
C22H29ClO5 (408.17034140000004)
(2e)-4-[(1s,3r,4s)-5-hydroxy-1,4-dimethoxy-7,8-dioxo-3-pentyl-3,4-dihydro-1h-2-benzopyran-6-yl]-2-methylbut-2-enoic acid
(1'r,2s,2's,3's,4's,8'r,9'r)-9'-(acetyloxy)-12'-[(acetyloxy)methyl]-3'-methyl-10'-oxaspiro[oxirane-2,7'-tricyclo[6.4.0.0²,⁴]dodecan]-11'-en-3'-ylmethyl acetate
3,8a-dimethyl-5-methylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h,4ah,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(1r,2e,8r,10r,11s)-6-(ethoxymethyl)-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
4,9-dimethyl-13-methylidene-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-5-one
5-(acetyloxy)-6-hydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,8h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[c]pyran-7-yl acetate
C17H28O11 (408.16315380000003)
(2e)-6-(ethoxymethyl)-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
(3as,4s,5s,11ar)-5-(acetyloxy)-6,10-bis(hydroxymethyl)-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
2-(2-{5-hydroxy-2-[(3,4,5-trihydroxyoxan-2-yl)oxy]phenyl}ethylidene)-6-methylhept-4-enoic acid
13-(acetyloxy)-1-hydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylpropanoate
5-(acetyloxy)-6,8-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(1s,6r,8r,12r,13s,23r)-16-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-11(25),15(20),16,18-tetraene-21,24-dione
(1r,2r,5s,7r,8r,10s,11z)-2,10-dihydroxy-11-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-5-(hydroxymethyl)-5-methoxy-8,10-dimethyl-4-oxatricyclo[6.2.2.0²,⁷]dodecane-9,12-dione
4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(3as,4r,4as,5r,7s,7as,9r,9ar)-4-(acetyloxy)-5,9-dihydroxy-4a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl (2z)-2-methylbut-2-enoate
(1r,2s,3s,4r,6s,8s)-3-(acetyloxy)-11-{[(1s)-3,3-dimethylcyclohexyl]methylidene}-10-oxo-5,7,9-trioxatricyclo[6.3.0.0²,⁶]undecan-4-yl acetate
(1r,4s,5r,7s,10s,11r,12r,13s,14s,18s,20r)-7,11,14,20-tetrahydroxy-4,13,17-trimethyl-3,9-dioxapentacyclo[10.8.0.0¹,⁵.0⁴,¹⁰.0¹³,¹⁸]icos-16-ene-8,15-dione
(1'r,2s,2's,3'r,4's,8'r,9'r)-9'-(acetyloxy)-12'-[(acetyloxy)methyl]-3'-methyl-10'-oxaspiro[oxirane-2,7'-tricyclo[6.4.0.0²,⁴]dodecan]-11'-en-3'-ylmethyl acetate
(3as,5s,6ar,9ar,9bs)-3,6,9-trimethylidene-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
18-acetyl 18-methyl (1s,10s,12r,13e)-13-ethylidene-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6,8-tetraene-18,18-dicarboxylate
(1s,2s,3r,4s,5r,7s,9s,14s,16s,18r)-2,7,10-trihydroxy-4-methoxy-1,7,9,16-tetramethyl-13,17-dioxapentacyclo[9.5.2.0³,¹⁴.0⁵,¹⁸.0¹⁴,¹⁸]octadec-10-ene-6,12-dione
7-(acetyloxy)-12-(hydroxymethyl)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylprop-2-enoate
(3as,6ar,8s,9ar,9bs)-3,6,9-trimethylidene-8-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(3as,5s,6ar,9ar,9bs)-3,6,9-trimethylidene-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
[5-(acetyloxy)-2-formyl-1,6-dimethylcyclohex-2-en-1-yl](2-hydroxy-4-methyl-5-oxo-2h-furan-3-yl)methyl 2-methylpropanoate
(1s,2z,4s,8r,9r,11r,13s)-13-(acetyloxy)-1-hydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylpropanoate
[(1r,2r,4s,5r,8r,9r)-9-(acetyloxy)-12-[(acetyloxy)methyl]-5-hydroxy-3-methyl-7-methylidene-10-oxatricyclo[6.4.0.0²,⁴]dodec-11-en-3-yl]methyl acetate
(3ar,4r,5r,6s,6ar,7r,9as,9br)-7-(acetyloxy)-4,6-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-5-yl 2-methylpropanoate
2,7,10-trihydroxy-4-methoxy-1,7,9,16-tetramethyl-13,17-dioxapentacyclo[9.5.2.0³,¹⁴.0⁵,¹⁸.0¹⁴,¹⁸]octadec-10-ene-6,12-dione
3,6,9-trimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
butyl (1r,3r,4s,5r)-1,3,4-trihydroxy-5-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]cyclohexane-1-carboxylate
2-[(1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}pentylidene)amino]butanedioic acid
7-(acetyloxy)-4,6-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-5-yl 2-methylpropanoate
[(1r,3r,5s,6s,8s)-6-hydroxy-1,3-dimethoxy-2-oxaspiro[4.5]decan-8-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(3as,5r,6ar,9ar,9bs)-3,6,9-trimethylidene-5-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(4ar,6r)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-6-(2-hydroxypropan-2-yl)-8a-methyl-hexahydropyrano[3,2-b]pyran-2-carboxylic acid
[(1r,2s,3r,5s,8s,9s,10s,11s,12r)-3,9,10-trihydroxy-12-methyl-6-methylidene-7-oxo-16,17-dioxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-12-yl]methyl acetate
(2s,3s,3as,4r,7r,7as)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2e)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)